Antimicrobial Agents and Chemotherapy · 2021 · 10 citations · 9 references
Life SciencesGeneticsInfectious DiseasesMedical GeneticsMicrobial GeneticsPharmacogeneticsAntifungal ResistanceDisease Resistance GeneticsFungal GeneticsFungal GenomicsFungal PathogenesisResistance GenesAntifungal Drug ResistanceAntifungal Resistance GeneticsAspergillosis TherapyAspergillus ResistanceFungal Drug ResistanceFungal Pathogenicity GeneticsInvasive Aspergillosis TreatmentPulmonary Aspergillosis
Triazole resistance in the pathogenic mold Aspergillus fumigatus has increased worldwide, posing a growing therapeutic challenge. Recently, mutations in the 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase gene ( hmg1 ) have been associated with triazole resistance. Here, we describe a novel E306K triazole resistance-conferring mutation in the HMG-CoA reductase gene from an Israeli patient with chronic cavitary pulmonary aspergillosis (CCPA).
9